Related Experiment Video
Updated: Jun 21, 2026

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
Published on: March 1, 2020
Tissue factor and cancer stem cells: is there a linkage?
Chloe Milsom1, Nathalie Magnus, Brian Meehan
1Montreal Children's Hospital, McGill University, QC, Canada.
Cancer coagulopathy involves deregulation of tissue factor (TF) and protease-activated receptors (PARs), impacting cancer stem cells (CSCs). Targeting the TF/PAR system may offer new cancer therapy strategies by influencing CSCs.
Area of Science:
- Oncology
- Hematology
- Molecular Biology
Background:
- Cancer progression frequently involves the coagulation system, termed cancer coagulopathy.
- Cancer cells and tumor stroma possess procoagulant properties, notably through tissue factor (TF) deregulation, influenced by oncogenes and tumor suppressors.
- Cancer stem cells (CSCs)/tumor-initiating cells (TICs) are crucial for tumor initiation and growth, relying on tumor vasculature for niche support.
Purpose of the Study:
- To investigate the role of the tissue factor (TF)/protease-activated receptor (PAR) system in cancer stem cell (CSC) biology and tumor progression.
- To explore how TF/PAR signaling contributes to CSC niche formation and influences tumor initiation, metastasis, recurrence, and treatment resistance.
- To propose targeting the TF/PAR system as a potential therapeutic strategy against cancer by modulating the CSC compartment.
Main Methods:
- Review and synthesis of existing evidence on cancer coagulopathy, TF expression, and CSC interactions.
- Analysis of oncogenic pathways (EGFR, K-ras, p53, PTEN) influencing TF expression in tumor cells.
- Examination of the TF/PAR system's role as a 'blood sensing' mechanism for cancer cells responding to plasma proteases and microenvironmental cues.
Main Results:
- Deregulation of TF expression is linked to oncogenic mutations and is observed in CSCs.
- The TF/PAR system acts as a signaling nexus, mediating interactions between CSCs and their vascular niche.
- Evidence suggests TF/PAR signaling influences CSC-driven tumor initiation, metastasis, recurrence, and therapeutic resistance.
Conclusions:
- The TF/PAR system plays a significant role in supporting the CSC niche and driving cancer progression.
- Targeting the TF/PAR system presents a novel therapeutic avenue for controlling cancer by affecting the CSC compartment.
- Further research into tumor cell- and host-derived TF is warranted to fully exploit this therapeutic opportunity.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
The Tumor Microenvironment
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

